Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells

Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells

US Patent 10596200 · Granted Mar 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac 2025
Efficient protein expression in vivo using modified RNA (mod-RNA)2025
Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating there2024
Genetic markers for engraftment of human cardiac ventricular progenitor cells2023
Methods for epicardial differentiation of human pluripotent stem cells2023
Methods for isolating human cardiac ventricular progenitor cells2022
Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac 2021
Serum-free human pluripotent stem cell culture medium2021
Genetic markers for engraftment of human cardiac ventricular progenitor cells2020
Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac 2020
Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac 2020
Methods for isolating human cardiac ventricular progenitor cells2019